Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells

Cellular and Molecular Life Sciences

Volumn 60, Issue 12, 2003, Pages 2679-2691

  De La Monte, S M ^a   Chen, G J ^a   Rivera, E ^a   Wands, J R ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Gene expression; Glycogen synthase kinase; Insulin; Microtubule associated proteins; Protein phosphorylation

Indexed keywords

CELL PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; NEURONAL THREAD PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROTUBULE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; BRAIN; CALCIUM-BINDING PROTEINS; HUMANS; INSULIN; LITHOSTATHINE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NERVE TISSUE PROTEINS; NEURONS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 0346731030     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3305-3     Document Type: Article

References (62)

1. de la Monte S. M., Ghanbari K., Frey W. H., Beheshti I., Averback P., Hauser S. L. et al. (1997) Characterization of the AD7c-NTP cDNA expression in Alzheimer's disease and measurement of the 41-kD protein in cerebrospinal fluid. J. Clin. Invest. 100: 1-12
2. de la Monte S. M., Carlson R. I., Brown N. V. and Wands J. R. (1996) Profiles of neuronal thread protein expression in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55: 1038-1050
3. de la Monte S. M., Ghanbari H., Ghanbari K., Averbach P. and Wands J. R. (1999) AD7c-NTP biomarker for Alzheimer's disease. Alz Reports 2: 327-332
4. Ghanbari H., Ghanbari K., Munzar M. and Averback P. (1998) Specificity of AD7c-NTP as a biochemical marker for Alzheimer's disease. J. Contemp. Neurol. 2: 2-6
5. Ghanbari H., Ghanbari K., Beheshti I., Munzar M., Vasauskas A. and Averback P. (1998) Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. J. Clin. Lab. Anal. 12: 285-288
6. Kahle P. J., Jakowec M., Teipel S. J., Hampel H., Petzinger G. M., Di Monte D. A. et al. (2000) Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology 54: 1498-1504
7. de la Monte S. M., Volicer L., Hauser S. L. and Wands J. R. (1992) Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 32: 733-742
8. de la Monte S. M. and Wands J. R. (1992) Neuronal thread protein over-expression in brains with Alzheimer's disease lesions. J. Neurol. Sci. 113: 152-164
9. Ozturk M., de la Monte S. M., Gross J. and Wands J. R. (1989) Elevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 86: 419-423
10. de la Monte S. M. and Wands J. R. (2001) Alzheimer-associated neuronal thread protein induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells. J. Neuropathol. Exp. Neurol. 60: 195-207
11. de la Monte S. M. and Wands J. R. (2001) Neurodegeneration changes in primary central nervous system neurons transfected with the Alzheimer- associated neuronal thread protein gene. Cell. Mol. Life Sci. 58: 844-849
12. de la Monte S. M. and Wands J. R. (2002) The AD7c-ntp neuronal thread protein biomarker for detecting Alzheimer's disease. Front. Biosci. 7: d989-996
13. de la Monte S. M., Xu Y. Y., Hutchins G. M. and Wands J. R. (1996) Developmental patterns of neuronal thread protein gene expression in Down syndrome. J. Neurol. Sci. 135: 118-125
14. de la Monte S. M., Garner W. and Wands J. R. (1997) Neuronal thread protein gene modulation with cerebral infarction. J. Cereb. Blood Flow Metab. 17: 623-635
15. de la Monte S. M., Xu Y. Y. and Wands J. R. (1996) Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease. J. Neurol. Sci. 138: 26-35
16. Xu Y. Y., Bhavani K., Wands J. R. and de la Monte S. M. (1995) Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression. Biochem. J. 125-132
17. Xu Y. Y., Bhavani K., Wands J. R. and de la Monte S. M. (1995) Insulin-induced differentiation and modulation of neuronal thread protein expression in primitive neuroectodermal tumor cells is linked to phosphorylation of insulin receptor substrate-1. J. Mol. Neurosci. 6: 91-108
18. Imahori K. and Uchida T. (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. 121: 179-188
19. de la Monte S. M., Chiche J., von dem Bussche A., Sanyal S., Lahousse S. A., Janssens S. P. et al. (2003) Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: relevance to Alzheimer's-type neurodegeneration. Lab. Invest. 83: 287-298
20. Sohn Y. K., Ganju N., Bloch K. D., Wands J. R. and de la Monte S. M. (1999) Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J. Neurol. Sci. 162: 133-151
21. de la Monte S. M., Lu B., Sohn Y., Etienne D., Kraft J., Ganju N. et al. (2000) Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration. Neurobiol. Aging 21: 309-319
22. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A. et al. (2002) Current Protocols in Molecular Biology, Wiley, New York
23. Sepe P. S., Lahousse S. A., Gemelli B., Chang H., Maeda T., Wands J. R. et al. (2002) Antisense inhibition of aspartyl (asparaginyl)-beta hydroxylase mediated neuroblastoma cell migration. Lab. Invest. 82: 881-891
24. Lavaissiere L., Jia S., Nishiyama M., de la Monte S., Stern A. M., Wands J. R. et al. (1996) Overexpression of human aspartyl(asparaginyl)beta- hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J. Clin. Invest. 98: 1313-1323
25. Fitzpatrick J., Munzar M., Fochi M., Bibiano R. and Averback P. (2000) 7c Gold urinary assay of neural thread protein in Alzheimer's disease. Alz. Reports 3: 155-159
26. Zhao W. and Alkon D. L. (2001) Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177: 125-134
27. Joshi R. L., Lamothe B., Cordonnier N., Mesbah K., Monthioux E., Jami J. et al. (1996) Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15: 1542-1547
28. Bruning J. C., Gautam D., Burks D. J., Gillette J., Schubert M., Orban P. C. et al. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125
29. Freychet P. (2000) Insulin receptors and insulin actions in the nervous system. Diabetes Metab. Res. Rev. 16: 390-392
30. Hoyer S. and Lannert H. (1999) Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann. N. Y. Acad. Sci. 893: 301-303
31. Beyreuther K., Bush A. I., Dyrks T., Hilbich C., Konig G., Monning U. et al. (1991) Mechanisms of amyloid deposition in Alzheimer's disease. Ann. N. Y. Acad. Sci. 640: 129-139
32. Behl C. and Sagara Y. (1997) Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives. J. Neural. Transm. Suppl. 49: 125-134
33. Probst A., Langui D., Ipsen S., Robakis N. and Ulrich J. (1991) Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol. 83: 21-29
34. de la Monte S. M. and Bloch K. D. (1997) Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease. Mol. Chem. Neuropathol. 30: 139-159
35. Hetman M., Cavanaugh J. E., Kimelman D. and Xia Z. (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20: 2567-2574
36. Eves E. M., Xiong W., Bellacosa A., Kennedy S. G., Tsichlis P. N., Rosner M. R. et al. (1998) Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18: 2143-2152
37. Rossig L., Badorff C., Holzmann Y., Zeiher A. M. and Dimmeler S. (2002) Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J. Biol. Chem. 277: 9684-9689
38. Hardt S. E. and Sadoshima J. (2002) Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90: 1055-1063
39. Kim H. S., Skurk C., Thomas S. R., Bialik A., Suhara T., Kureishi Y. et al. (2002) Regulation of angiogenesis by glycogen synthase kinase-3beta. J. Biol. Chem. 277: 41888-41896
40. Lucas F. R., Goold R. G., Gordon-Weeks P. R. and Salinas, P. C. (1998) Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J. Cell. Sci. 111 (Pt 10): 1351-1361
41. Salinas P. C. (1999) Wnt factors in axonal remodelling and synaptogenesis. Biochem. Soc. Symp. 65: 101-109
42. Krylova O., Messenger M. J. and Salinas P. C. (2000) Dishevelled-1 regulates microtubule stability: a new function mediated by glycogen synthase kinase-3beta. J. Cell. Biol. 151: 83-94
43. Sang H., Lu Z., Li, Y., Ru B., Wang W. and Chen J. (2001) Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. Neurosci. Lett. 312: 141-144
44. Sayas C. L., Avila J. and Wandosell F. (2002) Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3. Biochim. Biophys. Acta 1582: 144-153
45. Blair A. S., Hajduch E., Litherland G. J. and Hundal H. S. (1999) Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274: 36293-36299
46. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J. et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38: 555-565
47. Filippa N., Sable C. L., Filloux C., Hemmings B. and Van Obberghen E. (1999) Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 19: 4989-5000
48. Li M., Wang X., Meintzer M. K., Laessig T., Birnbaum M. J. and Heidenreich K. A. (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol. Cell. Biol. 20: 9356-9363
49. Pap M. and Cooper G. M. (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 273: 19929-19932
50. Doornbos R. P., Theelen M., van der Hoeven P. C., van Blitterswijk W. J., Verkleij A. J. and van Bergen en Henegouwen P. M. (1999) Protein kinase Czeta is a negative regulator of protein kinase B activity. J. Biol. Chem. 274: 8589-8596
51. Standaert M. L., Bandyopadhyay G., Antwi E. K. and Farese R. V. (1999) RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin. Endocrinology 140: 2145-2151
52. Tsujio I., Tanaka T., Kudo T., Nishikawa T., Shinozaki K., Grundke-Iqbal I. et al. (2000) Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett. 469: 111-117
53. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M. et al. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4: 1077-1086
54. de la Monte S. M. and Wands J. R. (2002) Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. Cell. Mol. Life Sci. 59: 882-893
55. Joachim C. L., Morris J. H., Selkoe D. J. and Kosik K. S. (1987) Tau epitopes are incorporated into a range of lesions in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 46: 611-622
56. Kosik K. S., Joachim C. L. and Selkoe D. J. (1986) Microtubule- associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA 83: 4044-4048
57. McKee A. C., Kosik K. S. and Kowall N. W. (1991) Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30: 156-165
58. Schmidt M. L., Lee V. M. and Trojanowski J. Q. (1990) Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am. J. Pathol. 136: 1069-1075
59. de la Monte S. M., Ng S. C. and Hsu D. W. (1995) Aberrant GAP-43 gene expression in Alzheimer's disease. Am. J. Pathol. 147: 934-946
60. Ihara Y. (1988) Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459: 138-144
61. Scheibel A. B. and Tomiyasu U. (1978) Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60: 1-8
62. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R. et al. (1991) Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6: 729-739